Chronic Care Management Reimbursement Trends

Physician participation in the chronic care management program is expected to grow to 70 percent of all practices by the third quarter of 2016, according to a new infographic by Smartlink Mobile. The infographic looks at the program's impact on physician practices and practices' understanding of the program requirements...

Spotlight

Glytec

Founded in 2006, Glytec is the pioneer and leader in diabetes therapy management software, enabling healthcare organizations to standardize acute and chronic care, and achieve best practice for glucose control. The company’s comprehensive eGlycemic Management System® (eGMS®) has been proven to dramatically reduce the drivers of cost and clinical variation, including hypoglycemia, readmissions, length of stay, complications and A1C levels. Its efficacy and safety have been validated by more than 60 research studies. eGMS® centers on an FDA-cleared insulin dosing solution that supports personalized intravenous and subcutaneous therapy for adult and pediatric populations.

Other Infographics
news image

How the COVID-19 pandemic has affected depression and anxiety around the world

Infographic | October 8, 2021

A report in The Lancet provides the first global estimates of the impact of the COVID-19 pandemic on mental health in 2020, and suggests an additional 53 million cases of major depressive disorder and 76 million cases of anxiety disorders were due to the pandemic. Even before the COVID-19 pandemic, major depressive disorder and anxiety disorders – which can increase the risk of other health outcomes such as suicide – were major contributors to the global burden of disease, affecting millions of men and women of all ages around the world. This study is the first to assess global impacts of the pandemic on major depressive disorder and anxiety disorders, quantifying the prevalence and burden of the disorders by age, sex, and location in 204 countries and territories in 2020.

Read More
news image

5 Things to Know About the Rapid Acceleration of Digital Health

Infographic | April 15, 2021

A silver lining from the COVID-19 global pandemic is the rapid acceleration of digital health and telemedicine. Check out the top 5 digital health trends in this infographic, courtesy ofReal Chemistry.

Read More
news image

WHO compendium of innovative health technologies for low-resource settings (2021)

Infographic | June 8, 2022

Health technologies are essential for a functioning health system. The response to the global COVID-19

Read More
news image

PII Theft in Healthcare

Infographic | May 26, 2021

Healthcare organizations must do more to authenticate personnel accessing patient data to prevent personal identifiable information (PII) theft and other security breaches. They must improve their defenses by implementing strong multi-factor authentication solutions that adhere to modern security standards like FIDO 2.0.

Read More
news image

Future Trends in Digital Healthcare 2022

Infographic | December 9, 2021

The global digital health market was valued at $96.5 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 15.1% from 2021 to 2028.

Read More
news image

New Survey Confirms Broken State of Healthcare Communications

Infographic | December 4, 2019

The healthcare industry has made many advances over the last few decades, yet one area where innovation is severely lacking is organization-wide communications. One of the most crucial, foundational aspects of the industry that almost single-handedly allows care to happen in the first place happens to be one of the major roadblocks for doctors, nurses, allied health professionals, and staff.

Read More

Spotlight

Glytec

Founded in 2006, Glytec is the pioneer and leader in diabetes therapy management software, enabling healthcare organizations to standardize acute and chronic care, and achieve best practice for glucose control. The company’s comprehensive eGlycemic Management System® (eGMS®) has been proven to dramatically reduce the drivers of cost and clinical variation, including hypoglycemia, readmissions, length of stay, complications and A1C levels. Its efficacy and safety have been validated by more than 60 research studies. eGMS® centers on an FDA-cleared insulin dosing solution that supports personalized intravenous and subcutaneous therapy for adult and pediatric populations.

Events